IDEXX Water Division Earns ISO/IEC-17025:2005 Accreditation
Accreditation saves time and improves efficiency by reducing the amount of quality control (QC) testing for customers
WESTBROOK, Maine, April 7, 2015—IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that the company’s QC facility for water microbiology has received ISO/IEC-17025:2005 accreditation from the ANSI-ASQ National Accreditation Board (ANAB). IDEXX, the leading provider of water microbiology tests worldwide, pursued this accreditation in order to offer its customers time-saving process efficiencies and the highest level of quality assurance possible. ISO/IEC-17025:2005 accreditation is based on a thorough evaluation of a facility’s quality management system and emphasizes continual product and process improvement. IDEXX earned the accreditation for their water QC testing facility after completing an extensive audit and third-party assessment.
“In addition to demonstrating that IDEXX operates according to internationally accepted criteria, this accreditation underscores IDEXX’s commitment to quality, accuracy and reliability,” said Manja Blazer, senior regulatory affairs manager at IDEXX. “Now laboratories all over the world that use IDEXX water tests can decrease QC testing, saving time and reducing costs.”
ISO/IEC-17025:2005 specifies the quality management and technical requirements that laboratories must meet in order to demonstrate technical competency and adherence to strict quality measures for testing, data reporting and process control in the laboratory. In most countries, ISO/IEC-17025:2005 is the standard that forms the basis of laboratory accreditation in order to be deemed technically competent. The scope of this ISO/IEC-17025:2005 accreditation includes IDEXX microbiology tests for total coliforms/Escherichia coli, enterococci, Pseudomonas aeruginosa and heterotrophic bacteria.
IDEXX can now provide customers with certificates of quality under the ISO/IEC-17025:2005 accreditation. In addition, its processes are in compliance with the new mandatory standard ISO 11133:2014 concerning the preparation, production, storage and performance testing of culture media for microbiology of food, animal feed and water. Customers can obtain certificates of quality for IDEXX water microbiology products by contacting their IDEXX representative.
About IDEXX Water
IDEXX Water is a global provider of water testing solutions that deliver easy, rapid, accurate and cost-effective information on water quality to laboratories and public utilities around the world. IDEXX entered the water testing market in 1993 with Colilert®, now one of the most frequently used testing methods for the detection of coliforms and Escherichia coli in water worldwide. In 2012, the IDEXX Colilert®-18/Quanti-Tray® Test method became ISO standard 9308-2:2012 for detecting total coliforms and Escherichia coli in water. For more information about IDEXX water products, visit idexx.com/water.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in over 175 countries.
Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” and similar words and expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at sec.gov, at various SEC reference facilities in the United States and via the Company’s website at idexx.com).
L. Manja R. Blazer, PhD
Senior Manager, Government Affairs and Market Development